Linked Life Data

21374065

Source:http://linkedlifedata.com/resource/pubmed/id/21374065

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2011-7-29
pubmed:abstractText
2,4,6-Trinitrobenzenesulfonic acid (TNBS)-induced colitis has been used as an inflammatory bowel disease (IBD), Crohn's disease (CD), preclinical model. However, published data on pharmacologic and therapeutic efficacy testing of this model are limited. FTY720 inhibits lymphoid cell trafficking in inflammatory conditions and is of interest to treat IBD.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1573-2568
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
56
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2283-91
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Pharmacologic evaluation of sulfasalazine, FTY720, and anti-IL-12/23p40 in a TNBS-induced Crohn's disease model.
pubmed:affiliation
Drug Safety R&D, Pfizer Worldwide Research and Development, 35 CambridgePark Dr, Cambridge, MA 02140, USA. zaher.radi@pfizer.com
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't